Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC);Sequentielle transarterielle chemoembolisation (TACE) des hepatozellulären karzinoms (HCC) - Erfahrungsbericht eines einzelnen zentrums über 5 jahre

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 179, Issue 3, 2007, Pages 289-299

  Herber, Sarcha Christian Alexander ^a   Otto, G ^a   Woerns, M ^a   Moench, C ^a   Kanzler, S ^a   Junginger, T ^a   Schneider, J ^a   Schuchmann, M ^a   Kummer, I ^a   Manzl, N ^a   Duber C ^a   Pitton, M B ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Abdomen; Chemoembolization; Hepatic arteries

Indexed keywords

DIPYRONE; IODINATED POPPYSEED OIL; MITOMYCIN C; PARACETAMOL; TROPISETRON;

ARTICLE; CANCER STAGING; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; TUMOR GROWTH; ADULT; AGED; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34247639582     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927355     Document Type: Article

References (40)

1. Llovet JM, Burroughs A, Bruix J. Hepatocelluar cracinoma. Lancet 2003; 6: 1907-1917
2. Bolondi L, Sofia S, Siringo S et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. ut 2001; 48: 251-259
3. Georgiades CS, Hong K, D'Angelo M et al. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 2005; 16: 1653-1659
4. Geschwind JF. Chemoembolization for hepatocellular carcinoma: where does the truth lie? J Vasc Interv Radiol 2002; 13: 991-994
5. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
6. Llovet JM, Real MI, Montana X et al. Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739
7. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171
8. Miller AB, Hoogstraten B, Staquet M et al. Reporting Results of Cancer treatment. Cancer 1981; 47: 207-214
9. Huppert PE, Lauchart W, Duda S et al. Chemoembolisation des hepatozellulären Karzinoms: Welche Faktoren bestimmen Therapieansprechen und Überleben? Fortschr Röntgenstr 2004; 176: 375-385
10. Sacks D, McClenny TE, Cardella JF et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14: S199-202
11. Llado L, Virgili J, Figueras J et al. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 2000; 88: 50-57
12. Saccheri S, Lovaria A, Sangiovanni A et al. Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas. J Vasc Interv Radiol 2002; 13: 995-999
13. Ueno K, Miyazono N, Inoue H et al. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors. Cancer 2000; 88: 1574-1581
14. Jaeger HJ, Mehring UM, Castaneda F et al. Sequential transarterial chemoembolization for unresectable advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol 1996; 19: 388-396
15. Hashimoto T, Nakamura H, Hori S et al. Hepatocellular carcinoma: efficacy of transcatheter oily chemoembolization in relation to macroscopic and microscopic patterns of tumor growth among 100 patients with partial hepatectomy. Cardiovasc Intervent Radiol 1995; 18: 82-86
16. Vogl TJ, Schroeder H, Trapp M et al. Multisequentielle arterielle Chemoembolisation fortgeschrittener hepatozellulärer Karzinome: Computertomographische Verlaufsparameter zur Beurteilung des Ansprechens auf die Therapie. Fortschr Röntgenstr 2000; 172: 43-50
17. Gonzalez-Uriarte J, Valdivieso A, Gastaca M et al. Liver transplantation for hepatocellular carcinoma in cirrhotic patients. Transplantation Proceedings 2003; 35: 1827-1829
18. Graziadei IW, Sandmueller H, Waldenberger P et al. Chemoembolization followed by liver transplantation für hepatocellular carcinoma impeds tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557-563
19. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40: 225-235
20. Colombo M. Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma. J Hepatol 1999; 31: 25-30
21. Cucchetti A, Vivarelli M, Piscaglia F et al. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. J Hepatol 2005; 43: 310-316
22. Saito Y, Matsuzaki Y, Doi M et al. Multiple regression analysis for assessing the growth of small hepatocellular carcinoma: the MIB-1 labeling index is the most effective parameter. J Gastroenterol 1998; 33: 229-235
23. Taouli B, Goh JS, Lu Y et al. Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr 2005; 29: 425-429
24. Lee HS, Kim JS, Choi IJ et al. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997; 79: 2087-2094
25. Becker G, Soezgen T, Olschewski M et al. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005; 11: 6104-6109
26. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332: 1256-1261
27. Testa R, Testa E, Giannini E et al. Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther 2003; 17: 1563-1569
28. Kiely JM, Rilling WS, Touzios JG et al. Chemoembolization in patients at high risk: results and complications. J Vasc Interv Radiol 2006; 17: 47-53
29. Decaens T, Roudot-Thoraval F, Bresson-Hadni S et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005; 11: 767-775
30. Greten TF, Papendorf F, Bleck JS et al. Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 2005; 92: 1862-1868
31. Herber S, Schneider J, Brecher B et al. TACE: Therapie des HCC vor Lebertransplantation - Erfahrungen. Fortschr Röntgenstr 2005; 177: 681-690
32. Biselli M, Andreone P, Gramenzi A et al. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study. Clin Gastroenterol Hepatol 2005; 3: 918-925
33. Kwok PC, Lam TW, Chan SC et al. A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma. J Hepatol 2000; 32: 955-964
34. Yuen MF, Chan AO, Wong BC et al. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol 2003; 98: 1181-1185
35. Lopez RR Jr, Pan SH, Hoffman AL et al. Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma. Arch Surg 2002; 137: 653-657; discussion 657-658
36. El Khaddari S, Gaudin JL, Abidi H et al. Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session. Gastroenterol Clin Biol 2002; 26: 728-734
37. Choi BI, Kim HC, Han JK et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 1992; 182: 709-713
38. Jung G, Poll L, Cohnen M et al. Dignitätsbeurteilung fokaler Leberläsionen mit der kontrastverstärkten MRT mit SHU 555 A im Vergleich zur nativen MRT und Multidetector Spiral-CT. Fortschr Röntgenstr 2005; 177: 1571-1577
39. Tsukioka G, Kakizaki S, Sohara N et al. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World J Gastroenterol 2006; 12: 48-53
40. Lubienski A, Bitsch RG, Schemmer P et al. Langzeitergebnisse von groβen, inoperablen hepatozellulären Karzinomen (HCC): signifikanter Überlebensvorteil von transarterieller Chemoembolisation (TACE) und perkutaner Ethanolinjektion (PEI) gegenüber TACE-Monotherapie. Fortschr Röntgenstr 2004; 176: 1794-1802